R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Director – Compliance

Regulatory Compliance & EthicsConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listedIn-person

About the Job

Requirements

  • At least 10 years of relevant experience, including in-house pharmaceutical experience developing compliance programs.
  • Demonstrated experience as an individual contributor managing a wide range of stakeholders and client groups, and building compliance capabilities in a scaling organization without direct reports.
  • Extensive experience with compliance matters relating to the development, approval and commercialization of pharmaceutical products in Europe.
  • Comprehensive knowledge of German anti-corruption and healthcare compliance laws, including Sections 299a and 299b StGB, the HWG, the AMG and the HinSchG; transparency and disclosure requirements; and applicable industry codes, including the FSA/AKG and vfa codes of conduct and the FSA Kodex.
  • Ability to apply risk-based analysis to compliance issues and develop solutions that satisfy business requirements and legal obligations.
  • Ability to work in a matrix organization, collaborate with business partners, influence peers, and interact with senior management and Field Force, Medical and Market Access teams.
  • Ability to manage and serve a wide range of client groups by responding quickly and pragmatically to urgent situations.
  • Demonstrated written and verbal communication, interpersonal and negotiation skills in one-on-one and group settings.
  • Organizational skills and problem-solving capabilities, and ability to perform in a fast-paced, high-volume, deadline-driven environment.
  • Confidence to advise stakeholders at all levels.
  • Judgment to liaise with Legal and business colleagues and/or outside counsel as needed.
  • Commitment to support other areas covered by a growing Compliance department.

Responsibilities

  • Lead the continuous development of Germany’s Healthcare Compliance Program in line with the global compliance strategy, ensuring alignment with organizational values and applicable German laws, regulations and industry codes.
  • Represent Compliance on the German Leadership team and serve as the primary compliance advisor to local Commercial and Medical teams, providing risk-based guidance across the product life cycle to enable launches and commercialization.
  • Collaborate across functions and regions to adapt and implement global compliance initiatives in Germany.
  • Oversee the review and approval of interactions with HCPs, HCOs, patient organizations, payors and government officials, including grants, sponsorships, speaker programs and advisory boards, and oversee certification of promotional and non-promotional materials and meetings.
  • Monitor and interpret legal, regulatory and industry-code developments in Germany, including Sections 299a and 299b StGB, the HWG, the AMG, the FSA/AKG and vfa codes of conduct (including the FSA Kodex), and the HinSchG, and advise the business on their operational impact.
  • Draft, implement and update compliance policies, procedures and guidance to ensure compliance with applicable German laws, regulations and industry codes.
  • Develop, deliver and monitor compliance training for employees in Germany, including field-based personnel, and designated third parties; coordinate with the works council (Betriebsrat), as appropriate, on co-determination requirements when implementing policies and training.
  • Foster a strong culture of compliance and integrity across the German organization.
  • Provide healthcare compliance expertise in developing compliance systems, tools and technology solutions that improve program efficiency and effectiveness for common HCP interactions.
  • Design and execute Germany’s risk assessment, monitoring and auditing plan, and lead remediation where necessary.
  • Administer local whistleblowing channels and support compliance investigations, including corrective and preventive action plans.
  • Own risk-based due diligence and ongoing monitoring of third parties, including distributors, agencies, consultants and vendors, under applicable anti-corruption and transparency requirements.
  • Support the Compliance Committee and transparency reporting obligations, and provide regular compliance reports to the Compliance Committee, Commercial Leadership, Medical Affairs and country management.
  • Act as compliance liaison with German regulators and industry associations, including BfArM, the Paul-Ehrlich-Institut, FSA and vfa, managing responses to code complaints, inquiries and investigations.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs